Mectizan Donation Program (MDP)


About MDP Onchocerciasis Lymphatic Filariasis MDP News Mectizan Expert Committee (MEC) News

Discovered and developed by Merck & Co. Inc., Mectizan is a very safe and highly effective drug approved for treatment of two of the world's most disfiguring and disabling tropical diseases. Click here to find out more about Mectizan...

Program
Information

History & Background

Onchocerciasis

Onchocerciasis treatments approved

Lymphatic Filariasis

Lymphatic Filariasis treatments approved

Mass Treatment

Humanitarian Program / Special requests for Mectizan

How to Apply/
Review Process

Technical Requirements

Program Partners

MDP Brochures

Mectizan Donation
Program News

NEW! "The Mectizan Donation Program—Highlights from 2005" published in the Filaria Journal (PDF)

NEW! "Towards the Elimination of Onchocerciasis" published in the Annals of Tropical Medicine and Parasitology (PDF)

NEW! Merck Mectizan Award Winners

Studies published on the impact of the Mectizan Donation Program

NEWSLETTER: The Mectizan Program Notes—current issue and archives

2006 Annual Highlights of the Mectizan Donation Program

Mectizan Expert Committee News

News from the Mectizan Expert Committee / Albendazole Coordination Meetings

Recommendations for the treatment of onchocerciasis with Mectizan in areas co-endemic for onchocerciasis and loiasis


	SIGN UP FOR OUR NEWSLETTER

Contact
	Mectizan® Donation Program (MDP) 325 Swanton Way Decatur, Georgia 30030 USA P: +1 (404) 371-1460 F: +1 (404) 371-1138 Contact Us

To sign up for our newsletter please email mectizan@taskforce.org

Program Information Onchocerciasis Lymphatic Filariasis
MDP News Mectizan Expert Committee News Contact Us Site Map